Sign in

    TERADYNE (TER)

    Q1 2025 Earnings Summary

    Reported on May 2, 2025 (After Market Close)
    Pre-Earnings Price$74.89Last close (Apr 29, 2025)
    Post-Earnings Price$73.68Open (Apr 30, 2025)
    Price Change
    $-1.21(-1.62%)
    • Record Robotics Order & Market Position: The company secured its largest robotics order ever from a strategic automotive customer while targeting underpenetrated advanced robotics segments—an initiative expected to help it significantly outgrow traditional industrial automation peers.
    • Winning Advanced Test Solutions: The firm’s recent HBM4 performance test win and strong acceptance of its system-level test (SLT) solution for AI accelerators underscore its technological leadership in semiconductor testing and position it for high‐value, long-term growth.
    • Stable Margins and Resilient Operations: Despite macro uncertainties and tariff impacts, competitive positioning has remained robust with a consistent 59%-60% gross margin target and disciplined cost controls, contributing to resilient operational performance.
    • Limited visibility into future performance: Executives repeatedly highlighted that their guidance and visibility beyond Q2 are very limited, creating uncertainty around full-year revenue and margin trends.
    • Headwinds in key end markets: Weakness in demand within segments such as Robotics, Mobile, and Automotive—exacerbated by tariff uncertainties and sluggish customer capital spending—could delay orders and strain growth.
    • Margin pressure amid declining product mix: The guidance for Q2 reflects lower gross margins compared to Q1, coupled with dependency on favorable product mix and higher operating expenses, which may further pressure margins if the weak end market continues.
    MetricYoY ChangeReason

    Total Revenue

    +14.4% (Q1 2025: $685.7M vs Q1 2024: $599.8M)

    Total Revenue grew rapidly due to strong performance in the semiconductor test segment and an improved product mix—especially in mobility—combined with robust demand in key regions like Asia Pacific, building on strategic shifts observed in prior periods.

    Net Income

    +54% (Q1 2025: $98.9M vs Q1 2024: $64.2M)

    Net Income surged as a result of significant operating leverage from higher-margins in the semiconductor test products and cost efficiencies; improved gross margins and a favorable revenue mix further bolstered profitability compared to the previous period.

    Income from Operations

    +55% (Q1 2025: $120.8M vs Q1 2024: $77.8M)

    Income from Operations increased markedly due to higher net revenues and enhanced cost management—driven largely by improvements in the semiconductor test segment and better operational execution relative to Q1 2024, reinforcing earlier positive trends.

    Semiconductor Test Revenue

    +31.6% (Q1 2025: $542.5M vs Q1 2024: $412.3M)

    Semiconductor Test Revenue experienced robust growth from increased sales—particularly in mobility tester segments—and expanded market share, continuing the upward momentum seen in previous reports and reflecting strategic market positioning.

    Robotics Revenue

    -21% (Q1 2025: $69M vs Q1 2024: $87.7M)

    Robotics Revenue declined significantly due to ongoing market challenges, lower sales volumes, and the impact of restructuring efforts; difficulties noted in earlier periods have persisted and worsened in Q1 2025.

    Asia Pacific Revenue

    +25.7% (Q1 2025: $532.41M vs Q1 2024: $423.67M)

    Asia Pacific Revenue grew strongly driven by increased semiconductor test sales in key markets such as Taiwan and China, building on previous momentum; conversely, revenue in other regions like EMEA declined, highlighting regional performance differences.

    Cash and Cash Equivalents

    -32.8% (Q1 2025: $475.63M vs Q1 2024: $707.40M)

    Cash and Cash Equivalents fell sharply due to aggressive capital allocation strategies—including share repurchases, dividend payments, and higher investing outflows for PP&E and acquisitions—marking a more assertive financial maneuver than in Q1 2024.

    MetricPeriodPrevious GuidanceCurrent GuidanceChange

    Sales

    Q2 2025

    $660 million – $700 million

    $610 million – $680 million

    lowered

    Non-GAAP EPS

    Q2 2025

    $0.58 – $0.68

    $0.41 – $0.64

    lowered

    Gross Margins

    Q2 2025

    58.5% – 59.5%

    56.5% – 57.5%

    lowered

    Operating Expenses (OpEx)

    Q2 2025

    41.5% – 42.5%

    40.5% – 44.5%

    raised

    Non-GAAP Operating Profit Rate

    Q2 2025

    17%

    14.5%

    lowered

    GAAP EPS

    Q2 2025

    no prior guidance

    $0.35 – $0.58

    no prior guidance

    SOC Test TAM

    FY 2025

    $4.7B – $5.1B (midpoint: $4.9B)

    no guidance

    no current guidance

    Memory TAM

    FY 2025

    $1.3B – $1.5B

    no guidance

    no current guidance

    Revenue Growth in Robotics

    FY 2025

    10%

    no guidance

    no current guidance

    Gross Margins

    FY 2025

    59% – 60%

    no guidance

    no current guidance

    Operating Expenses (OpEx)

    FY 2025

    Increase of 8% – 10% YoY

    no guidance

    no current guidance

    GAAP Tax Rate

    FY 2025

    15.25% (GAAP) / 15% (non-GAAP)

    no guidance

    no current guidance

    Share Buybacks

    FY 2025

    Up to $400 million

    no guidance

    no current guidance

    MetricPeriodGuidanceActualPerformance
    Revenue
    Q1 2025
    $660M – $700M
    $685.68M
    Met
    Gross Margin
    Q1 2025
    58.5% – 59.5%
    60.6% (calculated from $415,336 ÷ $685,680)
    Beat
    Operating Expenses
    Q1 2025
    41.5% – 42.5% of first-quarter sales
    43.0% (calculated from $294,533 ÷ $685,680)
    Missed
    TopicPrevious MentionsCurrent PeriodTrend

    Robotics Business Transformation

    Previously emphasized integration of UR and MiR units, restructuring to cut the breakeven revenue from $440M to $365M, and ongoing challenges in a weak market

    Emphasizes record orders from a global automotive customer, continued structural reorganization, and acknowledgement of near‐term macro challenges while banking on long‑term growth drivers (AI, onshoring)

    Consistent focus on transformation; restructuring persists with new record orders, though near‑term performance remains pressured

    Advanced Robotics Orders

    Prior calls highlighted channel growth through OEM initiatives, AI‐enabled product launches (e.g., AI accelerator, MiR1200 Pallet Jack), and strategic partnerships in shifting from traditional industrial automation

    Focus on the largest robotics order ever, integrated sales approach, and preparation to target underpenetrated advanced robotics markets with further restructuring efforts

    Steady strategic shift; emphasis on advanced orders reinforces the move from traditional automation with stronger order wins

    Semiconductor Test Business Growth (HBM & Advanced Test Solutions)

    Earlier periods described robust HBM testing growth (30% YoY increase in memory revenue, qualification for HBM performance tests) and milestones in advanced test solutions for AI compute

    Now highlights a major HBM4 performance test win (first DRAM wafer sort win), new post‑stack wafer test methods, and enhanced opportunities in AI compute testing (e.g., Titan HP system)

    Sustained momentum; new wins and improved testing approaches signal continued robust growth and competitive positioning

    Advanced Test Solutions for AI Accelerators & AI Integration

    Q2–Q4 2024 discussions focused on initial acceptance of system‑level tests, emerging opportunities in AI accelerator testing, and developments with Titan HP and AI toolkits

    Emphasizes system‑level test environment adoption, production acceptance for next‑generation AI accelerators, and first AI compute revenue as proof of concept

    Emerging as a revenue catalyst; growing market acceptance and early production wins underline its increasing importance

    Compute Segment Dynamics (VIP Engagement & Slowdown)

    Earlier calls reported strong compute growth driven by cloud AI, increased VIP engagement (upgraded systems and new socket opportunities), and robust compute TAM expansion with some concerns over “lumpy” orders

    Continues with high VIP engagement—shifting from upgrades to significant system orders—but with noted uncertainty for H2 of 2025 due to project timing and capacity challenges

    Transition to cautious outlook; sustained VIP traction contrasts with emerging near‑term uncertainties and slowdown concerns

    Operating Margins & Cost Control

    Previous periods maintained stable non‑GAAP margins around 22%, with rising OpEx due to accelerated investments (e.g., Semi Test engineering spend) and restructuring in robotics to achieve midterm targets

    Q1 2025 reported a 20.5% non‑GAAP margin with continued cost control measures (variable compensation, restructuring benefits) despite higher OpEx; robotics restructuring remains a key cost driver

    Continued focus on margin stability; effective cost controls and restructuring are in place even with rising strategic investments

    Market Visibility & Demand Uncertainty

    Visibility challenges were noted in Q2–Q4 2024 with limited forward guidance, seasonal pull‑ins/pull‑outs, and unpredictable customer forecasts affecting multiple segments

    Q1 2025 reiterated limited visibility beyond Q2, with customers pushing out orders (especially in mobile, memory, and robotics) due to trade policy and other uncertainties

    Consistency in uncertainty; limited guidance continues amid similar external pressures and demand fluctuations

    Mobile Market Recovery & Processor Complexity

    Earlier calls mentioned modest recovery potential, driven by improvements in utilization and increased complexity from AI integration and advanced nodes, while also noting challenges in refresh cycles

    Q1 2025 highlighted improved utilization rates, new image sensor tester shipments, and SLT opportunities to capture recovery; however, challenges remain with rising processor complexity and advanced testing needs

    Mixed sentiment; emerging recovery signals counterbalanced by ongoing challenges as processor complexity increases

    Macro Factors (Tariffs, Capital Spending & End Market Headwinds)

    Prior discussions noted industrial automation headwinds, modest capital spending delays, and macro factors affecting robotics and compute segments; tariffs were not prominent except in context of cost increases

    Q1 2025 provided explicit quantification of tariff impact (approximately $0.02 earnings effect in Q2) along with continued delays in capital spending in mobile and automotive, plus sequential headwinds in memory and robotics

    Persistent macro headwinds; continued challenges with capital spending and demand uncertainty, now with more detailed tariff impact analysis

    1. Margin Guidance
      Q: What is your full-year gross margin outlook?
      A: Management did not provide a full-year gross margin figure, noting first-half margins of roughly 59–60% with uncertainty for the second half due to revenue mix shifts.

    2. Robotics Order
      Q: Details on your largest robotics order?
      A: They reported their biggest robotics AMR order ever for an established automotive customer, highlighting its strategic importance and timing in Q1, with shipments starting promptly.

    3. Robotics Growth
      Q: Will robotics outgrow traditional peers?
      A: Management expects the robotics segment to significantly outperform industrial automation competitors, despite near-term headwinds from sluggish end markets.

    4. Memory Demand
      Q: What drives your Memory business trends?
      A: Management noted that DRAM will dominate, with NAND demand remaining low unless there are significant mobile volume increases or new interface protocols.

    5. Compute Guidance
      Q: Is the compute business on track?
      A: They expect the compute segment to remain in line with Investor Day guidance, though overall forecasting is challenging amid customer uncertainty.

    6. HBM Win
      Q: Can you clarify the HBM wafer start win?
      A: The HBM4 performance test win was achieved with a new customer for post-stack testing, not an extension of an existing HBM3 business.

    7. VIP TAM
      Q: Does VIP TAM include SLT revenue?
      A: The $600 million VIP TAM for '26 excludes SLT revenue, which if included would add around 10–30% to the figures over time.

    8. Order Pushouts
      Q: Are you seeing tariff-related order delays?
      A: Management observed pushouts primarily in the auto and industrial segments, with minimal tariff pull-ins impacting new capacity orders.

    9. Onshoring
      Q: Will onshoring boost back-end test volumes?
      A: They expect onshoring to affect shipment locations but not overall demand for testers, as capacity orders occur once wafer volumes are established.

    10. SLT Wins
      Q: What about the SLT wins in AI and mobile?
      A: They highlighted SLT as a strategic win for AI accelerators and mobile sockets, noting growing opportunities without implying a win at 2-nanometer.

    11. Tariff Impact
      Q: Has tariff pressure shifted international customer buying?
      A: Management stated competitive positioning remains stable, with no evidence that tariffs influenced customers to choose alternate vendors.

    12. Order Timing
      Q: When will the large order impact revenue?
      A: Shipments for the record robotics order will be spread from Q1 into Q2, without extending into the latter half of the year due to short lead times.

    13. Tester Utilization
      Q: How is tester utilization trending?
      A: They did not provide precise figures, only noting a qualitative improvement with fewer upgrade systems available compared to six months ago.

    14. HBM Stacked Die
      Q: Do you now test all three HBM dies on a stack?
      A: No, management clarified that the assumption of testing all three dies is incorrect.

    15. TAM Updates
      Q: When do shipping and TAM updates benefit the business?
      A: Initial queries on TAM and shipment timing were met with limited details, as management provided minimal follow-up on the first part of the question.

    Research analysts covering TERADYNE.